Skip to main navigation

Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Accept and Close

Privacy Policy

Advanced therapies for the sports medicine and severe burn care markets

About Vericel
Vision Mission & Values Patient Stories Executive Leadership Team Extended Leadership Team Board of Directors Vericel History Partnering with Vericel Corporate Compliance
Advanced Therapies
MACI Epicel NexoBrid Patents
Clinical Development
Pipeline Clinical Trials Clinical and Scientific Publications Grants
Careers
Open Positions Vericel Benefits
Investor Relations
Press Releases Events & Presentations Quarterly Results Stock Quote & Analyst Coverage Annual Reports & Proxies Statements ESG Report SEC Filings Corporate Governance Board of Directors FAQ Email Alerts Contact

Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

Quarterly Results

Quarterly Results

Show all

2023

Q4

Vericel Corporation Fourth Quarter 2023 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
Vericel Q4 2023 Earnings Presentation 426.4 KB
Form 10-K

Q3

Vericel Corporation Third Quarter 2023 Earnings Call
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
Vericel Q3 2023 Earnings Presentation 576 KB
Form 10-Q

Q2

Vericel Corporation Second Quarter 2023 Earnings Call
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
Vericel Q2 2023 Earnings Presentation 775.1 KB
Form 10-Q

Q1

Vericel Corporation First Quarter 2023 Earnings Call
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
Vericel Q1 2023 Earnings Presentation 518.4 KB
Form 10-Q

2022

Q4

Vericel Corporation Fourth Quarter 2022 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
Vericel Q4 2022 Earnings Presentation 1.2 MB
Form 10-K

Q3

Vericel Corporation Third Quarter 2022 Earnings Call
Vericel Reports Third Quarter 2022 Financial Results
Vericel Q3 2022 Earnings Presentation 943 KB
Form 10-Q

Q2

Vericel Corporation Second Quarter 2022 Earnings Call
Vericel Reports Second Quarter 2022 Financial Results
Vericel Q2 2022 Earnings Presentation 980.9 KB
Form 10-Q

Q1

Vericel Corporation First Quarter 2022 Earnings Call
Vericel Reports First Quarter 2022 Financial Results
Vericel Q1 2022 Earnings Presentation 1.4 MB
Form 10-Q

2021

Q4

Vericel Corporation Fourth Quarter 2021 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance
Vericel Q4 2021 Earnings Presentation 1.1 MB
Form 10-K

Q3

Vericel Corporation Third Quarter 2021 Earnings Call
Vericel Reports Third Quarter 2021 Financial Results
Vericel Q3 2021 Earnings Presentation 836.9 KB
Form 10-Q

Q2

Vericel Corporation Second Quarter 2021 Earnings Call
Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
Form 10-Q

Q1

Vericel Corporation First Quarter 2021 Earnings Call
Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
Form 10-Q

2020

Q4

Vericel Corporation Fourth Quarter 2020 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Full-Year 2021 Financial Guidance
Vericel Q4 2020 Earnings Presentation 818.9 KB
Form 10-K

Q3

Vericel Corporation Third Quarter 2020 Earnings Call
Vericel Reports Record Third Quarter Revenues and Net Income
Vericel Q3 2020 Earnings Presentation 1.2 MB
Form 10-Q

Q2

Vericel Corporation Second Quarter 2020 Earnings Call
Vericel Reports Second Quarter 2020 Financial Results
Vericel Q2 2020 Earnings Presentation 1.2 MB
Form 10-Q

Q1

Vericel Corporation First Quarter 2020 Earnings Call
Vericel Reports First Quarter 2020 Financial Results
Vericel Q1 2020 Earnings Presentation 1.3 MB
Form 10-Q

2019

Q4

Vericel Corporation Fourth Quarter 2019 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Full-Year 2020 Financial Guidance
Vericel Q4 2019 Earnings Presentation 1.4 MB
Form 10-K

Q3

Vericel Corporation Third Quarter 2019 Earnings Call
Vericel Reports Record Third Quarter Revenues, Net Income and Operating Cash Flow
Vericel Q3 2019 Earnings Presentation 1.4 MB
Form 10-Q

Q2

Vericel Corporation Second Quarter 2019 Earnings Call
Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
Vericel Q2 2019 Earnings Presentation 1.4 MB
Form 10-Q

Q1

Vericel Corporation First Quarter 2019 Earnings Call
Vericel Reports First Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
Vericel Q1 2019 Earnings Presentation 1.4 MB
Form 10-Q

2018

Q4

Vericel Corporation Fourh Quarter 2018 Earnings Call
Vericel Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Full-Year 2019 Financial Guidance
Form 10-K

Q3

Vericel Corporation Third Quarter 2018 Earnings Call
Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
Form 10-Q

Q2

Vericel Corporation Second Quarter 2018 Earnings Call
Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance
Form 10-Q

Q1

Vericel Corporation First Quarter 2018 Earnings Call
Vericel Reports First Quarter 2018 Financial Results
Form 10-Q

2017

Q4

Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
Form 10-K

Q3

Vericel Reports Third-Quarter 2017 Financial Results
Form 10-Q

Q2

Vericel Reports Second-Quarter 2017 Financial Results
Form 10-Q

Q1

Vericel Corporation First Quarter 2017 Earnings Call
Form 10-Q

2016

Q4

Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results
Form 10-K

Q3

Vericel Reports Third-Quarter 2016 Financial Results
Form 10-Q

Q2

Vericel Reports Second-Quarter 2016 Financial Results
Form 10-Q

Q1

Vericel Reports First-Quarter 2016 Financial Results
Form 10-Q

2015

Q4

Vericel Reports Fourth-Quarter and Year-End 2015 Financial Results
Form 10-K

Q3

Vericel Reports Third-Quarter 2015 Financial Results
Form 10-Q

Q2

Vericel Reports Second-Quarter 2015 Financial Results
Form 10-Q

Q1

Vericel Reports First-Quarter 2015 Financial Results
Form 10-Q

2014

Q4

Vericel Reports Fourth-Quarter and Year-End 2014 Financial Results
Form 10-K

Q3

Aastrom Biosciences Reports Third-Quarter 2014 Financial Results
Form 10-Q

Q2

Aastrom Biosciences Reports Second Quarter 2014 Financial Results
Form 10-Q

Q1

Aastrom Biosciences Reports First-Quarter 2014 Financial Results
Form 10-Q

Day High:
Day Low:
Volume:

on

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Company Presentation

Investor Presentation Title Slide

Company Presentation 2.6 MB

Contact Us | Corporate Compliance | Adverse Events Reporting | Expanded Access Policy

Terms and Conditions of Use | Privacy Policy | Community Guidelines | Medical Information Request Form

Vericel^® and the Vericel logo are registered trademarks of Vericel Corporation.
©2024 Vericel Corporation. All Rights Reserved.
Vericel Corporation 64 Sidney Street, Cambridge, MA 02139
Phone: (617) 588-5555 • Fax: (617) 588-5554 • mail@vcel.com